Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics

Abstract

Congenital hearing loss is one of the most common birth defects worldwide, with around 1 in 500 people experiencing some form of severe hearing loss. While over 400 different syndromes involving hearing loss have been described, it is important to be familiar with a wide range of syndromes involving hearing loss so an early diagnosis can be made and early intervention can be pursued to maximize functional hearing and speech-language development in the setting of verbal communication. This review aims to describe the presentation and genetics for some of the most frequently occurring syndromes involving hearing loss, including neurofibromatosis type 2, branchio-oto-renal syndrome, Treacher Collins syndrome, Stickler syndrome, Waardenburg syndrome, Pendred syndrome, Jervell and Lange-Nielsen syndrome, Usher syndromes, Refsum disease, Alport syndrome, MELAS, and MERRF.

Keywords

hearing loss - syndromic - sensorineural

• References

• 1 Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991; 630 (01) 16-31
• 2 Smith RJ, Bale Jr JF, White KR. Sensorineural hearing loss in children. Lancet 2005; 365 (9462): 879-890
• 3 Li XC, Friedman RA. Nonsyndromic hereditary hearing loss. Otolaryngol Clin North Am 2002; 35 (02) 275-285
• 4 Slattery WH. Neurofibromatosis type 2. Otolaryngol Clin North Am 2015; 48 (03) 443-460
• 5 Strasnick B, Glasscock III MEI, Haynes D, McMenomey SO, Minor LB. The natural history of untreated acoustic neuromas. Laryngoscope 1994; 104 (09) 1115-1119
• 6 Briggs RJ, Brackmann DE, Baser ME, Hitselberger WE. Comprehensive management of bilateral acoustic neuromas. Current perspectives. Arch Otolaryngol Head Neck Surg 1994; 120 (12) 1307-1314
• 7 Asthagiri AR, Parry DM, Butman JA. , et al. Neurofibromatosis type 2. Lancet 2009; 373 (9679): 1974-1986
• 8 Rouleau GA, Merel P, Lutchman M. , et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363 (6429): 515-521
• 9 Bashour AM, Meng JJ, Ip W, MacCollin M, Ratner N. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells. Mol Cell Biol 2002; 22 (04) 1150-1157
• 10 Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang L-S. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 2002; 23 (05) 736-748
• 11 Kalatzis V, Petit C. Branchio-Oto-Renal syndrome. Adv Otorhinolaryngol 2000; 56: 39-44
• 12 Chen A, Francis M, Ni L. , et al. Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 1995; 58 (04) 365-370
• 13 Smith RJH, Schwartz C. Branchio-oto-renal syndrome. J Commun Disord 1998; 31 (05) 411-420 , quiz 421
• 14 Ceruti S, Stinckens C, Cremers CW, Casselman JW. Temporal bone anomalies in the branchio-oto-renal syndrome: detailed computed tomographic and magnetic resonance imaging findings. Otol Neurotol 2002; 23 (02) 200-207
• 15 Fraser FC, Sproule JR, Halal F, Optiz JM. Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet 1980; 7 (03) 341-349
• 16 Abdelhak S, Kalatzis V, Heilig R. , et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997; 15 (02) 157-164
• 17 Kalatzis V, Abdelhak S, Compain S, Vincent C, Petit C. Characterization of a translocation-associated deletion defines the candidate region for the gene responsible for branchio-oto-renal syndrome. Genomics 1996; 34 (03) 422-425
• 18 Ruf RG, Xu PX, Silvius D. , et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004; 101 (21) 8090-8095
• 19 Hoskins BE, Cramer CH, Silvius D. , et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007; 80 (04) 800-804
• 20 Tadjuidje E, Hegde RS. The EYES absent proteins in development and disease. Cell Mol Life Sci 2013; 70 (11) 1897-1913
• 21 Trainor PA, Dixon J, Dixon MJ. Treacher Collins syndrome: etiology, pathogenesis and prevention. Eur J Hum Genet 2009; 17 (03) 275-283
• 22 Stovin JJ, Lyon Jr JA, Clemmens RL. Mandibulofacial dysostosis. Radiology 1960; 74 (02) 225-231
• 23 Phelps PD, Poswillo D, Lloyd GA. The ear deformities in mandibulofacial dysostosis (Treacher Collins syndrome). Clin Otolaryngol Allied Sci 1981; 6 (01) 15-28
• 24 Dixon J, Edwards SJ, Gladwin AJ. et al; The Treacher Collins Syndrome Collaborative Group. Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. Nat Genet 1996; 12 (02) 130-136
• 25 Fazen LE, Elmore J, Nadler HL. Mandibulo-facial dysostosis. (Treacher-Collins syndrome). Am J Dis Child 1967; 113 (04) 405-410
• 26 Rovin S, Dachi SF, Borenstein DB, Cotter WB. Mandibulofacial dysostosis, a familial study of five generations. J Pediatr 1964; 65: 215-221
• 27 Dauwerse JG, Dixon J, Seland S. , et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 2011; 43 (01) 20-22
• 28 Kadakia S, Helman SN, Badhey AK, Saman M, Ducic Y. Treacher Collins syndrome: the genetics of a craniofacial disease. Int J Pediatr Otorhinolaryngol 2014; 78 (06) 893-898
• 29 Snead MP, Yates JRW. Clinical and molecular genetics of Stickler syndrome. J Med Genet 1999; 36 (05) 353-359
• 30 Stickler GB, Hughes W, Houchin P. Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): a survey. Genet Med 2001; 3 (03) 192-196
• 31 Weingeist TA, Hermsen V, Hanson JW, Bumsted RM, Weinstein SL, Olin WH. Ocular and systemic manifestations of Stickler's syndrome: a preliminary report. Birth Defects Orig Artic Ser 1982; 18 (06) 539-560
• 32 Nowak CB. Genetics and hearing loss: a review of Stickler syndrome. J Commun Disord 1998; 31 (05) 437-453 ; 453–454
• 33 Webb AC, Markus AF. The diagnosis and consequences of Stickler syndrome. Br J Oral Maxillofac Surg 2002; 40 (01) 49-51
• 34 Opitz JM, France T, Herrmann J, Spranger JW. The Stickler syndrome. N Engl J Med 1972; 286 (10) 546-547
• 35 Jacobson J, Jacobson C, Gibson W. Hearing loss in Stickler's syndrome: a family case study. J Am Acad Audiol 1990; 1 (01) 37-40
• 36 Lucarini JW, Liberfarb RM, Eavey RD. Otolaryngological manifestations of the Stickler syndrome. Int J Pediatr Otorhinolaryngol 1987; 14 (2-3): 215-222
• 37 Helfgott SM, Mosciscki RA, San Martin J. , et al. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet 1991; 337 (8738): 387-389
• 38 Ahmad NN, Ala-Kokko L, Knowlton RG. , et al. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci U S A 1991; 88 (15) 6624-6627
• 39 Richards AJ, Yates JR, Williams R. , et al. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum Mol Genet 1996; 5 (09) 1339-1343
• 40 Vikkula M, Mariman EC, Lui VC. , et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995; 80 (03) 431-437
• 41 Acke FR, Dhooge IJ, Malfait F, De Leenheer EM. Hearing impairment in Stickler syndrome: a systematic review. Orphanet J Rare Dis 2012; 7: 84 . doi: 10.1186/1750-1172-7-84
• 42 Van Camp G, Snoeckx RL, Hilgert N. , et al. A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene. Am J Hum Genet 2006; 79 (03) 449-457
• 43 Baker S, Booth C, Fillman C. , et al. A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome. Am J Med Genet A 2011; 155A [phone]
• 44 Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows and noseroot with pigmentary anomalies of the iris and head hair and with congenital deafness; Dystopia canthi medialis et punctorum lacrimalium lateroversa, hyperplasia supercilii medialis et radicis nasi, heterochromia iridum totaliis sive partialis, albinismus circumscriptus (leucismus, polioss) et surditas congenita (surdimutitas). Am J Hum Genet 1951; 3 (03) 195-253
• 45 Read AP, Newton VE. Waardenburg syndrome. J Med Genet 1997; 34 (08) 656-665
• 46 Nayak CS, Isaacson G. Worldwide distribution of Waardenburg syndrome. Ann Otol Rhinol Laryngol 2003; 112 (9 Pt 1): 817-820
• 47 Cremers CWRJ, Smith RJH. , eds. Genetic Hearing Impairment: Its Clinical Presentations. Basel; New York: Karger; 2002
• 48 Liu XZ, Newton VE, Read AP. Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am J Med Genet 1995; 55 (01) 95-100
• 49 Hoth CF, Milunsky A, Lipsky N, Sheffer R, Clarren SK, Baldwin CT. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet 1993; 52 (03) 455-462
• 50 Shah KN, Dalal SJ, Desai MP, Sheth PN, Joshi NC, Ambani LM. White forelock, pigmentary disorder of irides, and long segment Hirschsprung disease: possible variant of Waardenburg syndrome. J Pediatr 1981; 99 (03) 432-435
• 51 Zaman A, Capper R, Baddoo W. Waardenburg syndrome: more common than you think!. Clin Otolaryngol 2015; 40 (01) 44-48
• 52 Tassabehji M, Read AP, Newton VE. , et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 1992; 355 (6361): 635-636
• 53 Sánchez-Martín M, Rodríguez-García A, Pérez-Losada J, Sagrera A, Read AP, Sánchez-García I. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 2002; 11 (25) 3231-3236
• 54 Wenzhi H, Ruijin W, Jieliang L. , et al. Heterozygous deletion at the SOX10 gene locus in two patients from a Chinese family with Waardenburg syndrome type II. Int J Pediatr Otorhinolaryngol 2015; 79 (10) 1718-1721
• 55 Attié T, Till M, Pelet A. , et al. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet 1995; 4 (12) 2407-2409
• 56 Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994; 8 (03) 251-255
• 57 Bondurand N, Dastot-Le Moal F, Stanchina L. , et al. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet 2007; 81 (06) 1169-1185
• 58 Kopp P. Pendred's syndrome: identification of the genetic defect a century after its recognition. Thyroid 1999; 9 (01) 65-69
• 59 Morgans ME, Trotter WR. Association of congenital deafness with goitre; the nature of the thyroid defect. Lancet 1958; 1 (7021): 607-609
• 60 Pendred V. Deaf-mutism and goitre. Lancet 1896; 148 (3808): 532
• 61 Fugazzola L, Mannavola D, Cerutti N. , et al. Molecular analysis of the Pendred's syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred's syndrome. J Clin Endocrinol Metab 2000; 85 (07) 2469-2475
• 62 Reardon W, Coffey R, Phelps PD. , et al. Pendred syndrome–100 years of underascertainment?. QJM 1997; 90 (07) 443-447
• 63 Fraser GR. Association of congenital deafness with goitre (Pendred's syndrome): a study of 207 families. Ann Hum Genet 1965; 28 (1–3): 201-249
• 64 Bizhanova A, Kopp P. Genetics and phenomics of Pendred syndrome. Mol Cell Endocrinol 2010; 322 (1–2): 83-90
• 65 Everett LA, Glaser B, Beck JC. , et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997; 17 (04) 411-422
• 66 Pera A, Villamar M, Viñuela A. , et al. A mutational analysis of the SLC26A4 gene in Spanish hearing-impaired families provides new insights into the genetic causes of Pendred syndrome and DFNB4 hearing loss. Eur J Hum Genet 2008; 16 (08) 888-896
• 67 Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957; 54 (01) 59-68
• 68 Komsuoğlu B, Göldeli O, Kulan K. , et al. The Jervell and Lange-Nielsen syndrome. Int J Cardiol 1994; 47 (02) 189-192
• 69 Neyroud N, Tesson F, Denjoy I. , et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997; 15 (02) 186-189
• 70 Tyson J, Tranebjaerg L, Bellman S. , et al. IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet 1997; 6 (12) 2179-2185
• 71 Schulze-Bahr E, Wang Q, Wedekind H. , et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997; 17 (03) 267-268
• 72 Öcal B, Imamoglu A, Atalay S, Ercan Tutar H. Prevalence of idiopathic long QT syndrome in children with congenital deafness. Pediatr Cardiol 1997; 18 (06) 401-405
• 73 Keats BJ, Corey DP. The Usher syndromes. Am J Med Genet 1999; 89 (03) 158-166
• 74 Petit C. Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet 2001; 2 (01) 271-297
• 75 Smith RJ, Berlin CI, Hejtmancik JF. , et al; Usher Syndrome Consortium. Clinical diagnosis of the Usher syndromes. Am J Med Genet 1994; 50 (01) 32-38
• 76 Gorlin RJ, Tilsner TJ, Feinstein S, Duvall III AJ. Usher's syndrome type III. Arch Otolaryngol 1979; 105 (06) 353-354
• 77 Auffarth GU, Tetz MR, Krastel H, Blankenagel A, Völcker HE. Complicated cataracts in various forms of retinitis pigmentosa. Type and incidence [in German]. Ophthalmologe 1997; 94 (09) 642-646
• 78 Pennings RJE, Wagenaar M, van Aarem A, Huygen PLM, Kimberling WJ, Cremers CWRJ. Hearing Impairment in Usher's Syndrome. Vol. 61. Karger Publishers; 2002:184_191. Available at: http://www.karger.com/Article/Abstract/66832 . Accessed February 8, 2017
• 79 Weil D, Blanchard S, Kaplan J. , et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995; 374 (6517): 60-61
• 80 Ko MK, Kenderling WJ, Friedman RA. Genetics of ear disorders. In: Cummings Otolaryngology. 6th ed. Elsevier; 2015: 2275-2284
• 81 Eudy JD, Weston MD, Yao S. , et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 1998; 280 (5370): 1753-1757
• 82 Weston MD, Eudy JD, Fujita S. , et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet 2000; 66 (04) 1199-1210
• 83 Boughman JA, Vernon M, Shaver KA. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis 1983; 36 (08) 595-603
• 84 Kimberling WJ, Hildebrand MS, Shearer AE. , et al. Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. Genet Med 2010; 12 (08) 512-516
• 85 Davies MG, Marks R, Dykes PJ, Reynolds D. Epidermal abnormalities in Refsum's disease. Br J Dermatol 1977; 97 (04) 401-406
• 86 Jansen GA, Ofman R, Ferdinandusse S. , et al. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet 1997; 17 (02) 190-193
• 87 van den Brink DM, Brites P, Haasjes J. , et al. Identification of PEX7 as the second gene involved in Refsum disease. Am J Hum Genet 2003; 72 (02) 471-477
• 88 Steinberg D. The metabolic basis of the Refsum syndrome. Birth Defects Orig Artic Ser 1971; 7 (01) 42-52
• 89 Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ. Identification of PAHX, a Refsum disease gene. Nat Genet 1997; 17 (02) 185-189
• 90 Wanders RJA, Waterham HR, Leroy BP. Refsum disease. In: Pagon RA, Adam MP, Ardinger HH. , et al, eds. GeneReviews®. Seattle, WA: University of Washington, Seattle; 1993. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK1353/ . Accessed February 11, 2017
• 91 Alport AC. Hereditary familial congenital haemorrhagic nephritis. BMJ 1927; 1 (3454): 504-506
• 92 Fallerini C, Dosa L, Tita R. , et al. Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet 2014; 86 (03) 252-257
• 93 Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M. Genetics of classic Alport's syndrome. Lancet 1988; 2 (8618): 1005-1007
• 94 Plant KE, Green PM, Vetrie D, Flinter FA. Detection of mutations in COL4A5 in patients with Alport syndrome. Hum Mutat 1999; 13 (02) 124-132
• 95 Streeten BW, Robinson MR, Wallace R, Jones DB. Lens capsule abnormalities in Alport's syndrome. Arch Ophthalmol 1987; 105 (12) 1693-1697
• 96 Kashtan C. Alport syndrome: facts and opinions. F1000 Res 2017; 6: 50
• 97 Merchant SN, Burgess BJ, Adams JC. , et al. Temporal bone histopathology in Alport syndrome. Laryngoscope 2004; 114 (09) 1609-1618
• 98 Hashimura Y, Nozu K, Kaito H. , et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. Kidney Int 2014; 85 (05) 1208-1213
• 99 Plevová P, Gut J, Janda J. Familial hematuria: a review. Medicina (Kaunas) 2017; 53 (01) 1-10
• 100 Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000; 58 (03) 925-943
• 101 Barker DF, Hostikka SL, Zhou J. , et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990; 248 (4960): 1224-1227
• 102 Morinière V, Dahan K, Hilbert P. , et al. Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 2014; 25 (12) 2740-2751
• 103 Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16 (04) 481-488
• 104 Ensink RJ, Camp GV, Cremers CW. Mitochondrial inherited hearing loss. Clin Otolaryngol Allied Sci 1998; 23 (01) 3-8
• 105 Nadol Jr JB, Merchant SN. Histopathology and molecular genetics of hearing loss in the human. Int J Pediatr Otorhinolaryngol 2001; 61 (01) 1-15
• 106 Zwirner P, Wilichowski E. Progressive sensorineural hearing loss in children with mitochondrial encephalomyopathies. Laryngoscope 2001; 111 (03) 515-521
• 107 Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348 (6302): 651-653
• 108 Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990; 61 (06) 931-937
• 109 Wallace DC, Zheng XX, Lott MT. , et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988; 55 (04) 601-610